Haystack Oncology Appoints Joel Kaufman as Chief Financial Officer
/PRNewswire/ -- Haystack Oncology ("Haystack"), an oncology company that applies the next generation of circulating tumor DNA (ctDNA) detection technology to...
Stay updated with breaking news from Haystack Oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Haystack Oncology ("Haystack"), an oncology company that applies the next generation of circulating tumor DNA (ctDNA) detection technology to...
Haystack Oncology Appoints Joel Kaufman as Chief Financial Officer - read this article along with other careers information, tips and advice on BioSpace
Also, Haystack Oncology raised a $56 million Series A, and Fearless earned a five-year contract with the National Archives and Records Administration.
Haystack Oncology Inc. has signed a lease for 20,000 square feet within the City Garage Science & Technology Center and plans to relocate to south Baltimore.
Haystack hopes to detect tiny, lingering traces of cancer in a person's body to help stop tumors from coming back.